SMT201300101B - Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio - Google Patents

Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio

Info

Publication number
SMT201300101B
SMT201300101B SM201300101T SM201300101T SMT201300101B SM T201300101 B SMT201300101 B SM T201300101B SM 201300101 T SM201300101 T SM 201300101T SM 201300101 T SM201300101 T SM 201300101T SM T201300101 B SMT201300101 B SM T201300101B
Authority
SM
San Marino
Prior art keywords
composition
water
oil type
emulsion
phase
Prior art date
Application number
SM201300101T
Other languages
English (en)
Italian (it)
Inventor
Frederic Lallemand
Jean-Sebastien Garrigue
Original Assignee
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa filed Critical Novagali Pharma Sa
Publication of SMT201300101B publication Critical patent/SMT201300101B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201300101T 2010-09-03 2013-09-18 Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio SMT201300101B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10175337.4A EP2425814B1 (en) 2010-09-03 2010-09-03 A water-in-oil type emulsion for treating a disease of the eye

Publications (1)

Publication Number Publication Date
SMT201300101B true SMT201300101B (it) 2013-11-08

Family

ID=43662067

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300101T SMT201300101B (it) 2010-09-03 2013-09-18 Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio

Country Status (10)

Country Link
EP (1) EP2425814B1 (pl)
CY (1) CY1114688T1 (pl)
DK (1) DK2425814T3 (pl)
ES (1) ES2426603T3 (pl)
HR (1) HRP20130830T1 (pl)
PL (1) PL2425814T3 (pl)
PT (1) PT2425814E (pl)
SI (1) SI2425814T1 (pl)
SM (1) SMT201300101B (pl)
UA (1) UA111168C2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3167064A1 (en) 2014-07-10 2017-05-17 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of usher syndrome type 2
GB201503408D0 (en) 2015-02-27 2015-04-15 Proqr Therapeutics N V Oligonucleotides
WO2017060317A1 (en) 2015-10-05 2017-04-13 Proqr Therapeutics Ii B.V. Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
CN113768879A (zh) * 2016-03-16 2021-12-10 苏州澳宗生物科技有限公司 依达拉奉剂型
WO2017177265A1 (en) * 2016-04-12 2017-10-19 Capsular Technologies Pty Ltd Injectable composition for delivery of a biologically active agent
US10617707B2 (en) 2016-04-25 2020-04-14 Proqr Therapeutics Ii B.V. Oligonucleotides to treat eye disease
GB201616202D0 (en) 2016-09-23 2016-11-09 Proqr Therapeutics Ii Bv Antisense oligonucleotides for the treatment of eye deisease
US11236333B2 (en) 2016-12-13 2022-02-01 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of Stargardt disease
WO2020015959A1 (en) 2018-07-19 2020-01-23 Stichting Katholieke Universiteit Antisense oligonucleotides rescue aberrant splicing of abca4.
EP3891282A1 (en) 2018-12-04 2021-10-13 Stichting Katholieke Universiteit Antisense oligonucleotides rescue aberrant splicing of abca4
JP2022518808A (ja) 2019-01-28 2022-03-16 プロキューアール セラピューティクス ツー ベスローテン フェンノートシャップ レーバー先天黒内障の処置のためのアンチセンスオリゴヌクレオチド
WO2020212567A1 (en) 2019-04-18 2020-10-22 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of usher syndrome
CN110090225B (zh) * 2019-04-19 2021-07-16 济南康和医药科技有限公司 一种依达拉奉氯化钠注射液及其制备方法
WO2021023863A1 (en) 2019-08-08 2021-02-11 Stichting Katholieke Universiteit Antisense oligonucleotides rescue aberrant splicing of abca4
IT201900019190A1 (it) 2019-10-17 2021-04-17 Univ Politecnica Delle Marche Derivato dell’epigallocatechina gallato
CA3166720A1 (en) 2020-03-04 2021-09-10 Jim SWILDENS Antisense oligonucleotides for use in the treatment of usher syndrome
WO2022090256A1 (en) 2020-10-26 2022-05-05 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of stargardt disease
WO2024074670A1 (en) 2022-10-06 2024-04-11 Stichting Radboud Universitair Medisch Centrum Antisense oligonucleotides for treatment of usher 2a. exon 68

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318539B1 (it) 2000-05-26 2003-08-27 Italfarmaco Spa Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
JP2005528352A (ja) * 2002-03-12 2005-09-22 エチファルム 生体活性物質の持続的放出に用いるためのゲル化特性を有する組成物
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US20110182877A1 (en) 2007-10-02 2011-07-28 Potentia Pharmaceuticals, Inc. Sustained delivery of compstatin analogs from gels

Also Published As

Publication number Publication date
PT2425814E (pt) 2013-09-02
SI2425814T1 (sl) 2013-10-30
UA111168C2 (uk) 2016-04-11
CY1114688T1 (el) 2016-10-05
DK2425814T3 (da) 2013-09-08
EP2425814B1 (en) 2013-06-19
HRP20130830T1 (en) 2013-10-11
ES2426603T3 (es) 2013-10-24
EP2425814A1 (en) 2012-03-07
PL2425814T3 (pl) 2013-11-29

Similar Documents

Publication Publication Date Title
SMT201300101B (it) Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio
MY157513A (en) A water-in-oil type emulsion for treating a disease of the eye
AR121843A2 (es) Formulación oftálmica y método para mejorar la presbicia
BRPI0607606A2 (pt) formulações lìquidas para tratamento de doenças ou condições
BRPI0821683B8 (pt) uso de um agonista parassimpático e de um antagonista simpático ou um agonista simpático para tratar presbiopia, miopia, hipermetropia, emetropia e/ou astigmatismo, e/ou para melhorar a visão noturna ou de baixa luz
AR085662A1 (es) Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
AR082150A1 (es) N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolin-3-carboxamida deuterada, sales y usos de la misma, metodo de tratamiento, mezcla compuestos, composicion farmaceutica, proceso de preparacion, compuesto enriquecido con deuterio
RU2016105581A (ru) Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
MY195618A (en) Use of a Long Acting Glp-1/Glucagon Receptor Dual Agonist for the Treatment of Non-Alcoholic Fatty Liver Disease
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
EA201590902A1 (ru) Способы и устройства, применяемые для лечения глазных болезней у человека
JP2014532654A5 (pl)
EA201490163A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
BR112013027674A2 (pt) "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
SMT201300095B (it) Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia
NZ602635A (en) Methods of enhancing drug delivery and effectiveness of therapeutic agents
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
EA201790406A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
BR112016015763B8 (pt) preparação farmacêutica incluindo composto de ácido piridilaminocético, e, uso da mesma
AR094291A1 (es) Formulacion inyectable de liberacion prolongada que comprende tolvaptan opticamente activo, y un procedimiento para producirla
BR112014031154A2 (pt) agente profilático e/ou terapêutico para deficiência cognitiva leve; e agente de melhoria do fluxo intersticial
CO6190533A2 (es) Sal xinafoato de un compuesto de 5-oxazol-2-il-quinolina sustituido